Literature DB >> 13433788

Essential blepharospasm.

J W HENDERSON.   

Abstract

Entities:  

Keywords:  EYELIDS/diseases

Mesh:

Year:  1956        PMID: 13433788      PMCID: PMC1312648     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


× No keyword cloud information.
  9 in total

1.  Lid paresis induced by oculomotor akinesia.

Authors:  J E LEBENSOHN
Journal:  Am J Ophthalmol       Date:  1954-09       Impact factor: 5.258

2.  The extrapyramidal system: an inquiry into the validity of the concept.

Authors:  R MEYERS
Journal:  Neurology       Date:  1953-09       Impact factor: 9.910

3.  Relief of intractable blepharospasm; a preliminary report.

Authors:  S A FOX
Journal:  Am J Ophthalmol       Date:  1951-10       Impact factor: 5.258

4.  Corticofugal degeneration following thermocoagulation of areas 4, 6 and 4-s in Macaca mulatta.

Authors:  W J Verhaart
Journal:  J Anat       Date:  1940-01       Impact factor: 2.610

5.  SURGICAL ANATOMY OF THE FACIAL NERVE: With reference to the technique of orbicularis block (palpebral akinesia).

Authors:  M Klein
Journal:  Br J Ophthalmol       Date:  1946-11       Impact factor: 4.638

6.  SENILE BLEPHAROSPASM.

Authors:  K E Madan
Journal:  Br J Ophthalmol       Date:  1927-08       Impact factor: 4.638

7.  [Case of blepharospasm successfully treated by unilateral ramisection of the facial nerve].

Authors:  A HONEK; F ZIZKA
Journal:  Cas Lek Cesk       Date:  1951-06-15

8.  The Surgical Treatment of Blepharospasm.

Authors:  C H Frazier
Journal:  Ann Surg       Date:  1931-06       Impact factor: 12.969

  9 in total
  10 in total

1.  OPERATION FOR BLEPHAROSPASM.

Authors:  G SCASSELLATISFORZOLINI
Journal:  Br J Ophthalmol       Date:  1964-03       Impact factor: 4.638

2.  Clinical features of patients with blepharospasm: a report of 240 patients.

Authors:  E L Peckham; G Lopez; E A Shamim; S Pirio Richardson; S Sanku; R Malkani; M Stacy; P Mahant; A Crawley; A Singleton; M Hallett
Journal:  Eur J Neurol       Date:  2011-03       Impact factor: 6.089

3.  Clinical outcomes of individualized botulinum neurotoxin type A injection techniques in patients with essential blepharospasm.

Authors:  Youngje Sung; Sang Min Nam; Helen Lew
Journal:  Korean J Ophthalmol       Date:  2015-03-17

4.  Botulinum toxin type A therapy for blepharospasm.

Authors:  Gonçalo S Duarte; Filipe B Rodrigues; Raquel E Marques; Mafalda Castelão; Joaquim Ferreira; Cristina Sampaio; Austen P Moore; João Costa
Journal:  Cochrane Database Syst Rev       Date:  2020-11-19

5.  [Idiopathic blepharospasm. Clinical and electrophysiological investigations in 27 patients (author's transl)].

Authors:  E Schenck; D Schmidt
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1978-12-14

6.  Blepharospasm: a case study comparison of trihexyphenidyl (Artane) versus EMG biofeedback.

Authors:  P J Brantley; C L Carnrike; M E Faulstich; C A Barkemeyer
Journal:  Biofeedback Self Regul       Date:  1985-06

7.  Surgical management of essential blepharospasm.

Authors:  A K Bates; B L Halliday; C S Bailey; J R Collin; A C Bird
Journal:  Br J Ophthalmol       Date:  1991-08       Impact factor: 4.638

8.  Effect of treatment with botulinum toxin on neurogenic blepharospasm.

Authors:  J S Elston; R W Russell
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-22

Review 9.  How Many Dystonias? Clinical Evidence.

Authors:  Alberto Albanese
Journal:  Front Neurol       Date:  2017-02-03       Impact factor: 4.003

10.  SURGICAL ASPECT OF BLEPHAROSPASM TREATMENT: A CASE REPORT.

Authors:  Kristijan Dinjar; Vedran Zubčić; Andrijana Kopić; Vlatko Kopić; Bruno Popić; Dubravka Holik
Journal:  Acta Clin Croat       Date:  2020-06       Impact factor: 0.780

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.